Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
UB-311 Alzheimer's Disease (Phase 3) United Neuroscience Amyloid-Related Immunotherapy (active)